AstraZeneca gets BRILINTA FDA approval for reducing risk of stroke in acute ischemic stroke or high-risk transient ischemic attack

BRILINTA FDA approval : AstraZeneca has bagged approval for BRILINTA (ticagrelor) from the US  Food and Drug Administration for its use in reducing the risk ... Read More